The Forest Service asserts its aims are “to provide a lower bound,” “to ‘complete’ the range of SCC values,” and to counterbalance the 95th percentile estimate.47 This choice misunderstands the nature and purpose of the Interagency Working Group’s range of four values in general, and of the 95th percentile estimate in particular it contradicts the Office of Information and Regulatory Affair’s gui. The Forest Service’s Application of a 10th Percentile Estimate Misunderstands the SCC’s Treatment of Uncertainty and Is Inconsistent with Federal Practices The Interagency Working Group on the Social Cost of Carbon-which included representatives from the Forest Service’s parent agency, the Department of Agriculture-carefully developed a range of four Social Cost of Carbon values intended for unifo. in the history and sociology of science and a master's degree (MBE) in bioethics.įor more information, please visit. in classics, and the University of Pennsylvania, where he received a Ph.D. Schwartz is a graduate of Princeton University, where he received an A.B. Public Health Service-led STD research in Guatemala in the 1940s. He was also a staff member for President Barack Obama's Presidential Commission for the Study of Bioethical Issues, where he was a lead staff author of the Commission's 2010 report on synthetic biology and emerging technologies and a contributor to its 2011 investigation of U.S. Shapiro Fellow at the Princeton University Center for Human Values, and earlier, an Associate Fellow and Lecturer in the Department of Medical Ethics and Health Policy at the University of Pennsylvania Perelman School of Medicine. Prior to arriving at Yale, Schwartz was the Harold T. He also advised colleges and universities, K-12 schools, early childhood centers, churches, and other organizations regarding their COVID-19 policies and protocols, particularly with respect to vaccines. Ned Lamont's COVID-19 Vaccine Advisory Group and chair of its Science Subcommittee. Thomas More Catholic Chapel & Center at Yale.ĭuring the COVID-19 pandemic, Schwartz was a member of Connecticut Gov. He is a member of The Lance t Commission on Vaccine Acceptance in the United States, the New England Comparative Effectiveness Public Advisory Council for the Institute for Clinical and Economic Review (ICER), and the Board of Trustees of St. House Oversight Subcommittee on Economic and Consumer Policy, the National Vaccine Advisory Committee, and the Presidential Commission for the Study of Bioethical Issues. His research, analysis, and perspectives have appeared in the New York Times, Washington Post, CNN, NPR, BBC, Time, and elsewhere. health care system, pharmaceuticals and the FDA, science advice to government, and related topics. Schwartz regularly teaches courses and gives lectures on vaccination issues, health policy and the U.S. Other ongoing projects examine how policy-makers, regulators, payers, physicians, and patients evaluate and respond to the risks, benefits, and costs of medical interventions. This project is supported by the National Institutes of Health. Among his current research projects is a book, Solicited Advice : Expert Committees, Government Health Agencies, and Medicine in Modern America, that examines the emergence, evolution, and continuing influence of expert advisory committees in American medicine and public health from the 1960s to the present, particularly regarding pharmaceuticals, vaccines, and screening technologies. He is also an author of the chapter titled “Ethics” in Plotkin's Vaccines, the leading textbook of vaccine science and policy, and editor of Vaccination Ethics and Policy: An Introduction with Readings. Schwartz's publications have appeared in The New England Journal of Medicine, The Journal of the American Medical Association (JAMA), The American Journal of Public Health, BMJ, The Lancet, Health Affairs, and elsewhere. He holds a secondary appointment in the Section of the History of Medicine at the Yale School of Medicine and is also affiliated with Yale's Institution for Social and Policy Studies and Program in the History of Science and Medicine. The overall focus of his work is on the ways in which evidence is interpreted, evaluated, and translated into regulation and policy in medicine and public health. His research examines vaccines and vaccination policy, decision-making in medical regulation and public health policy, and the structure and function of scientific expert advice to government. Schwartz is an Associate Professor in the Department of Health Policy and Management at the Yale School of Public Health.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |